Edwards Lifesciences (EW) Treasury Shares (2009 - 2026)

Edwards Lifesciences' Treasury Shares history runs 18 years deep, the most recent figure standing at $7.5 billion for Q1 2026.

• In Q1 2026, Treasury Shares rose 16.48% year-over-year to $7.5 billion; the TTM figure through Mar 2026 stood at $7.5 billion (up 16.48% YoY), while the FY2025 annual figure was $7.1 billion, up 14.52% from the prior year.
• Treasury Shares was $7.5 billion for Q1 2026 at Edwards Lifesciences, up from $7.1 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $83.0 million in Q1 2026 to a low of $1.1 million in Q3 2022.
• Historically, Treasury Shares has averaged $44.1 million across 5 years, with a median of $43.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares jumped 71.46% in 2022, then rose 14.37% in 2024.
• A 5-year view of Treasury Shares shows it stood at $4.1 billion in 2022, then grew by 21.25% to $5.0 billion in 2023, then gained by 23.24% to $6.2 billion in 2024, then rose by 14.52% to $7.1 billion in 2025, then increased by 5.95% to $7.5 billion in 2026.
• The last three Treasury Shares figures came in at $7.5 billion (Q1 2026), $7.1 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.